Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00701909 · ClinicalTrials.gov registry record · Phase 3
Pain Medicine for Wound Care Procedures
A Phase 3 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 12
- Enrollment target
NCT00701909 is a Phase 3 study that has completed, run by University of California, San Francisco. The registered enrollment target is 12 participants.
The verdict
NCT00701909, a Phase 3 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a randomized double-blind study to determine if the administration of a small-dose of ketamine (an anesthetic)added to morphine (an opioid) contributes to reducing pain intensity during open wound care procedure (WCP)in patients who have had a traumatic injury and are in an Intensive Care Unit. Patients will be randomized to receive morphine plus saline (a placebo) or morphine plus ketamine before the WCP. The second time the patient is scheduled for WCP (no less than 24 hours), patients will be crossed over to receive the treatment they did not receive the first time. It is hypothesized that patients who receive the combination of morphine and ketamine will have better pain control during the procedure than patients who just receive morphine.
Interventions
- DRUG Morphine plus Ketamine
- DRUG Morphine plus Saline (placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00701909
The ClinicalTrials.gov registry entry for NCT00701909 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Morphine plus Ketamine is the first listed.
NCT00701909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00701909 about?
NCT00701909 is a clinical study titled "Pain Medicine for Wound Care Procedures". This is a randomized double-blind study to determine if the administration of a small-dose of ketamine (an anesthetic)added to morphine (an opioid) contributes to reducing pain intensity during open wound care procedure (WCP)in patients who have had a traumatic injury and are in an Intensive Care Un...
What is the current status of trial NCT00701909?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 12 participants. The study started on 2008-06. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00701909?
The interventions under investigation include: Morphine plus Ketamine (DRUG), Morphine plus Saline (placebo) (DRUG).
Who is sponsoring clinical trial NCT00701909?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.